October 5th 2021
Rachid Baz, MD, discusses the role of alkylating agents in relapsed/refractory multiple myeloma.
September 29th 2021
Rachid Baz, MD, discusses the utility of venetoclax in patients with heavily pretreated multiple myeloma.
September 5th 2018
Rachid Baz, MD, associate member, head of the Myeloma Section at Moffitt Cancer Center, discusses the potential use of selinexor (KPT-330) in patients with multiple myeloma.
May 26th 2017
Rachid Baz, MD, hematologist and medical oncologist, Moffitt Cancer Center, discusses how treatment approaches vary for patients with multiple myeloma.